Aplastic anemia (AA) is a rare immunologically mediated bone marrow failure syndrome,
characterized by progressive loss of hematopoietic stem cells resulting in peripheral …

Background For patients who do not have a suitable human leukocyte antigen (HLA)-
matched family donor, unrelated donor registries of adult volunteers and banked umbilical …

Hematopoietic stem cell transplantation (HSCT) is a definite cure for many hematological
diseases. With the increasing indications for HSCT and its relatively low cost in Indian …

Autologous stem cell transplantation (ASCT) is considered as standard of care in patients
with multiple myeloma (MM) patients aged 65 years or younger. We analyzed data of 94 …

Multiple myeloma (MM) is a neoplastic disorder, which accounts for 13% of all hematological
malignancies globally. While, conventional chemotherapy used to be the mainstay treatment …

We describe our experience of first 50 consecutive hematopoietic stem‐cell transplants
(HSCT) done between 2007 and 2012 at the Apollo Hospital, Gandhinagar, 35 autologous …

Purpose Hematopoietic stem cell transplant (HSCT) is an intense form of treatment, resulting
in major symptom burden but can prove curative. The quality of life (QOL) is a major …

Stem cell transplant (SCT) is the “standard of care” for several malignant disorders such as
leukemia as well as nonmalignant disorders such as thalassemia and aplastic anemia. In …

Total 26 children of thalassemia underwent hematopoetic stem cell transplantation from
September 2006 to December 2014. Out of these 17 were matched sibling transplantation …

Background: Haematopoietic stem cell transplantation (HSCT) is the standard consolidation
therapy for a variety of malignant and non-malignant diseases in children and adults. Our …